Recombinant human Arylsulfatase A (rhASA)
HGT-MLD-048
Phase 2 mab completed
Quick answer
Recombinant human Arylsulfatase A (rhASA) for Late Infantile Metachromatic Leukodystrophy is a Phase 2 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Late Infantile Metachromatic Leukodystrophy
- Phase
- Phase 2
- Modality
- mab
- Status
- completed